Global Glucagon Market Insights, Forecast to 2025

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The classification of glucagon includes inject glucagon and nasal glucagon, and now almost all the product is the type of injection. In 2018, Eli Lilly will launch the nasal glucagon in the market.
Glucagon is widely used in emergency kits, general use, diagnostic & motility, cardiogenic shock and other field. The most proportion of Glucagon is emergency kits, which is about 335 in2016.
North America is the largest consumption place, with a consumption market share nearly 41% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Glucagon market is valued at 430 million US$ in 2018 and will reach 700 million US$ by the end of 2025, growing at a CAGR of 6.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glucagon market based on company, product type, end user and key regions.

This report studies the global market size of Glucagon in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Glucagon in these regions.
This research report categorizes the global Glucagon market by top players/brands, region, type and end user. This report also studies the global Glucagon market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals

Market size by Product
Inject Glucagon
Nasal Glucagon
Market size by End User
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Glucagon market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Glucagon market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Glucagon companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Glucagon submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Glucagon are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Glucagon market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions